DOI QR코드

DOI QR Code

Intra-tracheal Administration of the Disinfectant Chloromethylisothiazolinone/methylisothiazolinone (CMIT/MIT) in a Pregnant Mouse Model for Evaluating Causal Association with Stillbirth

가습기살균제 CMIT/MIT의 기도 점적투여를 통한 임신마우스의 사산에 대한 영향

  • Kang, Byoung-Hun (GLP Center & Dept. of Toxicity Assessment, Daegu Catholic University) ;
  • Kim, Min-Sun (College of Pharmacy, Sunchon National University) ;
  • Park, Yeong-Chul (GLP Center & Dept. of Toxicity Assessment, Daegu Catholic University)
  • 강병훈 (대구가톨릭대학교 GLP센터 & 화학물질독성평가학과) ;
  • 김민선 (순천대학교 약학대학 약학과) ;
  • 박영철 (대구가톨릭대학교 GLP센터 & 화학물질독성평가학과)
  • Received : 2018.09.20
  • Accepted : 2018.10.20
  • Published : 2018.10.28

Abstract

Objectives: Recently, a report was published that the humidifier disinfectant CMIT/MIT did not cause developmental toxicity and was not detected in systemic circulation as a result of an inhalation toxicity test. Therefore, this study was carried out to investigate any associations between CMIT/MIT exposure and developmental toxicity using the in vivo apical toxicity test method. Methods: Groups of pregnant ICR mice were instilled in the trachea with chloromethylisothiazolinone/methylisothiazolinone (CMIT/MIT) using a visual instillobot over a period of seven days from days 11 to 17 days post-coitum. For the in vivo apical toxicity test method, an $LD_{50}$-based dose-range finding model was applied to decide the dose range for inducing developmental toxicity. Results: Among the groups of 0, 0.1, 0.5, 1.0, and 1.5 mg ai/kg/day CMIT/MIT, the exposure groups of 0.5 mg and 1.0 ai/kg/day CMIT/MIT were estimated to reflect the thresholds for the stillbirth and death of pregnant mice, respectively. The groups of 0.5, 1.0, and 1.5 mg ai/kg/day CMIT/MIT induced stillbirth rates of 2.57, 10, and 53.8%, respectively. Another exposure group of 0.75 mg ai/kg/day CMIT/MIT did not induce any deaths of pregnant mice and resulted in a stillbirth rate of 8% in only one of six pregnant mice. Conclusions: CMIT/MIT can induce stillbirth in pregnant mice. It was also concluded that CMIT/MIT moves through the pulmonary circulation system and then continues on through systemic circulation and the placenta. There is a possibility of stillbirth and other health causalities in humans beyond the lungs caused by CMIT/MIT exposure.

Keywords

References

  1. Park DU, Ryu SH, Lim HK, Kim SK, Cho YY, Ahn JJ, et al. Types of householdhumidifier disinfectant and associated risk of lung injury (HDLI) in South Korea. Sci Total Environ. 2017; 596-597: 53-60. https://doi.org/10.1016/j.scitotenv.2017.04.040
  2. Asian Citizen's Center for Environment and Health. Humidifier disinfectant manufacturer Prosecutor recall and report center installation request Available: http://ecopoll.bomnae.net/bbs/board.php?bo_table=sub02_04&wr_id=171&sca=2016%EB%85%84&page=4 [accessed 2016].
  3. Kim HY, Park YC, Chung YH. Intra-tracheal Administration of the Disinfectant Chloromethylisothiazolinone/methylisothiazolinone (CMIT/MIT) in a Mouse Model to Evaluate a Causal Association with Death. J Environ Health Sci. 2017; 43(4): 247-256.
  4. Park YC. The molecular and biochemical principles of toxicology. Korea: Korean studies Information Publishing Company Press; 2010.
  5. Williams TM. The mechanism of action of isothiazolone biocides. Power Plant Chemistry. 2007; 9(1): 14-22.
  6. Collier PJ, Ramsey A, Waigh RD, Douglas KT, Austin P, Gilbert P. Chemical reactivity of some isothiazolone biocides. J Appl Bacteriol. 1990; 69(4): 578-84. https://doi.org/10.1111/j.1365-2672.1990.tb01551.x
  7. Basic Module in Bioorganic Chemistry. Reaction of isothiazolinones with glutathione. VAK 02-317-7-406 WS 2007/2008. Available: http://chem.uft. unibremen.de/ranke/pdf/isothiazolone_GSH_bmb.pdf [accessed 2008].
  8. Yonhapnews. Shin CH. "Dept of Environment, The toxicity of CMIT.MIT not observed in animal toxicity test". Available: http://www.yonhapnews.co.kr/bulletin/2018/03/21/0200000000AKR2018032113700001HTML [accessed 21 March 2018].
  9. Adami HO, Berry SC, Breckenridge CB, Smith LL, Swenberg JA, Trichopoulos D, et al. Toxicology and Epidemiology: Improving the Science with a Framework for Combining Toxicological and Epidemiological Evidence to Establish Causal Inference. Toxicol Sci. 2011; 122(2): 223-234. https://doi.org/10.1093/toxsci/kfr113
  10. OECDiLibrary. OECD Guidelines for the Testing of Chemicals, Section 4; Health Effects. Available: www.oecd-ilibrary.org/ [accessed 2018].
  11. ICH. M3(R1): Maintenance of the ICH Guideline on Non-Clinical Safety Studies for the Conduct of Human Clinical Trials for Pharmaceuticals; 2000.
  12. Hacker M, Messer WS, Bachmann KA. Pharmacology: Principles and Practice. United States: Academic Press; 2009. p. 353-369.
  13. Bhattacharya S, Zhang Q, Carmichael PL, Boekelheide K, Andersen ME. Toxicity Testing in the 21st Century: Defining New Risk Assessment Approaches Based on Perturbation of Intracellular Toxicity Pathways. PLoS ONE. 2011; 6(6): 1-11.
  14. Rhomberg LR, Goodman JE, Haber LT, Dourson M, Andersen ME, Klaunig JE, et al. Linear lowdose extrapolation for noncancer health effects is the exception, not the rule. Crit Rev Toxicol. 2011; 41(1): 1-19. https://doi.org/10.3109/10408444.2010.536524
  15. A white paper for Humidifier disinfectants-induced health injury. Inspection Committee for lung damage Korea Centers for Disease Control and Prevention Press; 2014. p. 44-49.
  16. Keller DA, Juberg DR, Catlin N, Farland WH, Hess FG, Wolf DC, et al. Identification and Characterization of Adverse Effects in 21st Century Toxicology. Toxicol Sci. 2012; 126(2): 291-297. https://doi.org/10.1093/toxsci/kfr350
  17. EU SCIENCE HUB. Toxicity Pathways-from concepts to application in chemical safety assessment. Available: http://publications.jrc.ec.europa.eu/repository/bitstream/JRC86467/lb-na-26389-en-n%20.pdf [accessed 2013].
  18. Krewski D, Andersen ME, Mantus E, Zeise L. Toxicity Testing in the 21st Century: Implications for Human Health Risk Assessment. Risk Analysis. 2009; 29(4): 474-497. https://doi.org/10.1111/j.1539-6924.2008.01150.x
  19. Pastoor T, Stevens J. Historical perspective of the cancer bioassay. Scand J Work Environ Health. 2005; 31(1): 129-40.
  20. NATIONAL INSTITUTE OF ENVIRONMENTAL RESEARCH. Study on health effects caused by toxic chemical-containing household product. Available: http://webbook.me.go.kr/DLi-File/NIER/06/021/5591231.pdf [accessed December 2014].
  21. Ko MSH. Embryogenomics: developmental biology meets genomics. TRENDS in Biotechnology. 2001; 19(12): 511-518. https://doi.org/10.1016/S0167-7799(01)01806-6
  22. Organization for Economic Cooperation and Development (OECD). OECD Guidelines 425 for the testing of chemicals: Acute Oral Toxicity-Up-and-Down Procedure. 2001.
  23. Vit PJ. Approximate lethal dose versus median lethal dose in acute toxicity testing of pharmaceuticals. Arch Toxicol. 1989; 63(4): 343-344. https://doi.org/10.1007/BF00278650
  24. Chiaratti MR, Malik S, Diot A, Rapa E, Macleod L, Morten K, et al. Is Placental Mitochondrial Function a Regulator that Matches Fetal and Placental Growth to Maternal Nutrient Intake in the Mouse?. PLOS ONE. 2015.
  25. Dumollard R, Duchen M, Carroll J. The role of mitochondrial function in the oocyte and embryo. Current topics in developmental. 2007; 77: 21-49.
  26. Gambling L, Kennedy C, McArdle HJ. Iron and copper in fetal development. Seminars in Cell & Developmental Biology. 2011; 22(6): 637-644. https://doi.org/10.1016/j.semcdb.2011.08.011
  27. Milczarek R, Sokolowska E, Rybakowska I, Kaletha K, Klimek J. Paraquat inhibits progesterone synthesis in human placental mitochondria. Placenta. 2016; 43: 41-46. https://doi.org/10.1016/j.placenta.2016.04.019
  28. Holland OJ, Hickey AJR, Alvsaker A, Moran S, Hedges C, Chamley LW, et al. Changes in mitochondrial respiration in the human placenta over gestation. Placenta. 2017; 57: 102-112. https://doi.org/10.1016/j.placenta.2017.06.011
  29. Mattison DR, Thomford PJ. The Mechanisms of Action of Reproductive Toxicants. Toxicologic Pathology. 1989; 17(2): 364-376. https://doi.org/10.1177/019262338901700213